Cargando…

Agonistic autoantibodies against ß2-adrenergic receptor influence retinal microcirculation in glaucoma suspects and patients

PURPOSE: Agonistic β2-adrenergic receptor autoantibodies (β2-agAAb) have been observed in sera of patients with ocular hypertension and open-angle glaucoma (OAG). They target the β2-receptors on trabecular meshwork, ciliary body and pericytes (Junemann et al. 2018; Hohberger et al. 2019). In additio...

Descripción completa

Detalles Bibliográficos
Autores principales: Hohberger, Bettina, Hosari, Sami, Wallukat, Gerd, Kunze, Rudolf, Krebs, Johann, Müller, Meike, Hennig, Till, Lämmer, Robert, Horn, Folkert, Muñoz, Luis E., Herrmann, Martin, Mardin, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8104926/
https://www.ncbi.nlm.nih.gov/pubmed/33961631
http://dx.doi.org/10.1371/journal.pone.0249202
_version_ 1783689512523661312
author Hohberger, Bettina
Hosari, Sami
Wallukat, Gerd
Kunze, Rudolf
Krebs, Johann
Müller, Meike
Hennig, Till
Lämmer, Robert
Horn, Folkert
Muñoz, Luis E.
Herrmann, Martin
Mardin, Christian
author_facet Hohberger, Bettina
Hosari, Sami
Wallukat, Gerd
Kunze, Rudolf
Krebs, Johann
Müller, Meike
Hennig, Till
Lämmer, Robert
Horn, Folkert
Muñoz, Luis E.
Herrmann, Martin
Mardin, Christian
author_sort Hohberger, Bettina
collection PubMed
description PURPOSE: Agonistic β2-adrenergic receptor autoantibodies (β2-agAAb) have been observed in sera of patients with ocular hypertension and open-angle glaucoma (OAG). They target the β2-receptors on trabecular meshwork, ciliary body and pericytes (Junemann et al. 2018; Hohberger et al. 2019). In addition to their influence on the intraocular pressure, an association to retinal microcirculation is discussed. This study aimed to investigate foveal avascular zone (FAZ) characteristics by en face OCT angiography (OCT-A) in glaucoma suspects and its relationship to β2-agAAb status in patients with OAG. MATERIAL AND METHODS: Thirty-four patients (28 OAG, 6 glaucoma suspects) underwent standardized, clinical examination including sensory testing as white-on-white perimetry (Octopus G1, mean defect, MD) and structural measures as retinal nerve fibre layer (RNFL) thickness, neuroretinal rim width (BMO-MRW), retinal ganglion cell layer (RGCL) thickness, and inner nuclear layer (INL) thickness with high-resolution OCT. FAZ characteristics were measured by OCT-A scans of superficial vascular plexus (SVP), intermediate capillary plexus (ICP), and deep capillary plexus (DCP). FAZ-R was calculated (area FAZ (SVP)/area FAZ (ICP)). Using cardiomyocyte bioassays we analysed serum samples for the presence of β2-agAAb. RESULTS: (I) Total mean FAZ area [mm(2)]: 0.34±0.16 (SVP), 0.24±0.12 (ICP), and 0.49±0.24 (DCP); mean FAZ-R 1.58±0.94. No correlation was seen for FAZ-R with MD, RNFL, BMO-MRW, RGCL thickness and INL thickness (p>0.05). (II) ß2-agAAb have been observed in 91% patients and showed no correlation with MD, RNFL, BMO-MRW, RGCL thickness and INL thickness (p>0.05). (III) FAZ-R correlated significantly with the β2-agAAb-induced increase of the beat rate of cardiomyocyte (p = 0.028). CONCLUSION: FAZ characteristics did not correlate with any glaucoma associated functional and morphometric follow-up parameter in the present cohort. However, level of β2-agAAb showed a significantly correlation with FAZ-ratio. We conclude that β2-agAAb might be a novel biomarker in glaucoma pathogenesis showing association to FAZ-ratio with OCT-A.
format Online
Article
Text
id pubmed-8104926
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-81049262021-05-18 Agonistic autoantibodies against ß2-adrenergic receptor influence retinal microcirculation in glaucoma suspects and patients Hohberger, Bettina Hosari, Sami Wallukat, Gerd Kunze, Rudolf Krebs, Johann Müller, Meike Hennig, Till Lämmer, Robert Horn, Folkert Muñoz, Luis E. Herrmann, Martin Mardin, Christian PLoS One Research Article PURPOSE: Agonistic β2-adrenergic receptor autoantibodies (β2-agAAb) have been observed in sera of patients with ocular hypertension and open-angle glaucoma (OAG). They target the β2-receptors on trabecular meshwork, ciliary body and pericytes (Junemann et al. 2018; Hohberger et al. 2019). In addition to their influence on the intraocular pressure, an association to retinal microcirculation is discussed. This study aimed to investigate foveal avascular zone (FAZ) characteristics by en face OCT angiography (OCT-A) in glaucoma suspects and its relationship to β2-agAAb status in patients with OAG. MATERIAL AND METHODS: Thirty-four patients (28 OAG, 6 glaucoma suspects) underwent standardized, clinical examination including sensory testing as white-on-white perimetry (Octopus G1, mean defect, MD) and structural measures as retinal nerve fibre layer (RNFL) thickness, neuroretinal rim width (BMO-MRW), retinal ganglion cell layer (RGCL) thickness, and inner nuclear layer (INL) thickness with high-resolution OCT. FAZ characteristics were measured by OCT-A scans of superficial vascular plexus (SVP), intermediate capillary plexus (ICP), and deep capillary plexus (DCP). FAZ-R was calculated (area FAZ (SVP)/area FAZ (ICP)). Using cardiomyocyte bioassays we analysed serum samples for the presence of β2-agAAb. RESULTS: (I) Total mean FAZ area [mm(2)]: 0.34±0.16 (SVP), 0.24±0.12 (ICP), and 0.49±0.24 (DCP); mean FAZ-R 1.58±0.94. No correlation was seen for FAZ-R with MD, RNFL, BMO-MRW, RGCL thickness and INL thickness (p>0.05). (II) ß2-agAAb have been observed in 91% patients and showed no correlation with MD, RNFL, BMO-MRW, RGCL thickness and INL thickness (p>0.05). (III) FAZ-R correlated significantly with the β2-agAAb-induced increase of the beat rate of cardiomyocyte (p = 0.028). CONCLUSION: FAZ characteristics did not correlate with any glaucoma associated functional and morphometric follow-up parameter in the present cohort. However, level of β2-agAAb showed a significantly correlation with FAZ-ratio. We conclude that β2-agAAb might be a novel biomarker in glaucoma pathogenesis showing association to FAZ-ratio with OCT-A. Public Library of Science 2021-05-07 /pmc/articles/PMC8104926/ /pubmed/33961631 http://dx.doi.org/10.1371/journal.pone.0249202 Text en © 2021 Hohberger et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Hohberger, Bettina
Hosari, Sami
Wallukat, Gerd
Kunze, Rudolf
Krebs, Johann
Müller, Meike
Hennig, Till
Lämmer, Robert
Horn, Folkert
Muñoz, Luis E.
Herrmann, Martin
Mardin, Christian
Agonistic autoantibodies against ß2-adrenergic receptor influence retinal microcirculation in glaucoma suspects and patients
title Agonistic autoantibodies against ß2-adrenergic receptor influence retinal microcirculation in glaucoma suspects and patients
title_full Agonistic autoantibodies against ß2-adrenergic receptor influence retinal microcirculation in glaucoma suspects and patients
title_fullStr Agonistic autoantibodies against ß2-adrenergic receptor influence retinal microcirculation in glaucoma suspects and patients
title_full_unstemmed Agonistic autoantibodies against ß2-adrenergic receptor influence retinal microcirculation in glaucoma suspects and patients
title_short Agonistic autoantibodies against ß2-adrenergic receptor influence retinal microcirculation in glaucoma suspects and patients
title_sort agonistic autoantibodies against ß2-adrenergic receptor influence retinal microcirculation in glaucoma suspects and patients
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8104926/
https://www.ncbi.nlm.nih.gov/pubmed/33961631
http://dx.doi.org/10.1371/journal.pone.0249202
work_keys_str_mv AT hohbergerbettina agonisticautoantibodiesagainstß2adrenergicreceptorinfluenceretinalmicrocirculationinglaucomasuspectsandpatients
AT hosarisami agonisticautoantibodiesagainstß2adrenergicreceptorinfluenceretinalmicrocirculationinglaucomasuspectsandpatients
AT wallukatgerd agonisticautoantibodiesagainstß2adrenergicreceptorinfluenceretinalmicrocirculationinglaucomasuspectsandpatients
AT kunzerudolf agonisticautoantibodiesagainstß2adrenergicreceptorinfluenceretinalmicrocirculationinglaucomasuspectsandpatients
AT krebsjohann agonisticautoantibodiesagainstß2adrenergicreceptorinfluenceretinalmicrocirculationinglaucomasuspectsandpatients
AT mullermeike agonisticautoantibodiesagainstß2adrenergicreceptorinfluenceretinalmicrocirculationinglaucomasuspectsandpatients
AT hennigtill agonisticautoantibodiesagainstß2adrenergicreceptorinfluenceretinalmicrocirculationinglaucomasuspectsandpatients
AT lammerrobert agonisticautoantibodiesagainstß2adrenergicreceptorinfluenceretinalmicrocirculationinglaucomasuspectsandpatients
AT hornfolkert agonisticautoantibodiesagainstß2adrenergicreceptorinfluenceretinalmicrocirculationinglaucomasuspectsandpatients
AT munozluise agonisticautoantibodiesagainstß2adrenergicreceptorinfluenceretinalmicrocirculationinglaucomasuspectsandpatients
AT herrmannmartin agonisticautoantibodiesagainstß2adrenergicreceptorinfluenceretinalmicrocirculationinglaucomasuspectsandpatients
AT mardinchristian agonisticautoantibodiesagainstß2adrenergicreceptorinfluenceretinalmicrocirculationinglaucomasuspectsandpatients